Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AM Rx vs boostAGErx

AM Rx
Graded #490

Lower grade

vs+16.199999999999996
boostAGErx
Graded #201

Higher grade

The verdict

boostAGErx takes it — 66.1/100 to 49.9/100.

boostAGErx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. boostAGErx is a longevity-focused telehealth service selling compounded GLP-1 weight management alongside peptide therapy.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueboostAGErx +23
51
74
Dose & formulationAM Rx +1
65
64
Clinical oversightboostAGErx +33
41
74
Labs & monitoringboostAGErx +3
49
52
FulfillmentboostAGErx +27
58
85
Contract termsboostAGErx +5
20
25
AM Rx · left barboostAGErx · right bar

The numbers

MetricAM RxboostAGErx
WeighScore49.9/10066.1/100
GradeCC
Scorecard rank#490#201
Semaglutide$151/mo (quarterly plan, plus a separate fee, compounded)$95/mo (billed every 28 days, compounded)
TirzepatideNot disclosed$145/mo (billed every 28 days, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
AM Rx

Graded #490 · C

Strengths

  • Insurance coordination for brand-name GLP-1s — as low as $25/mo
  • All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • HSA and FSA accepted
  • Video visits available with providers averaging 10+ years' experience
  • Compounded semaglutide from $151/mo on the quarterly plan

Where it loses points

  • Active FTC/DOJ lawsuit over deceptive billing and subscription practices
  • Novo Nordisk false-advertising lawsuit (Aug 2025)
  • Parent company Zealthy holds a BBB D- rating with 2,370+ complaints
  • Trustpilot 2.0/5, with 85% one-star reviews citing billing disputes and unreachable support
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
boostAGErx

Graded #201 · C

Strengths

  • Compounded GLP-1 starting around $95/mo (12-month plan paid upfront)
  • Free shipping and clinical evaluation included
  • Membership fee refunded in full if you're not approved
  • Also offers peptide therapy such as sermorelin
  • 100% online with licensed providers — no clinic visit

Where it loses points

  • Billing runs on a 28-day cycle rather than a calendar month — thirteen charges a year, so the $145 tirzepatide rate is $1,885 a year, an effective $157/mo
  • The terms call the charge a 'membership fee' while the marketing carousel says 'No Membership Fees Ever'
  • Prices are rendered entirely in JavaScript; the page's HTML body is empty, so nothing is readable without running the bundle
  • Shipped compounded medication is non-refundable
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard